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Bone marrow stromal cell (BMSC)‐mediated endochondral bone formation may be a
promising alternative to the current gold standards of autologous bone transplantation,
in the development of novel methods for bone repair. Implantation of chondrogenically
differentiated BMSCs leads to bone formation in vivo via endochondral ossification. The
success of this bone formation in an allogeneic system depends upon the interaction
between the implanted constructs and the host immune system. The current study inves-
tigated the effect of chondrogenically differentiated human bone marrow stromal cell
(hBMSC) pellets on the maturation and function of dendritic cells (DCs) by directly
coculturing bone forming chondrogenic hBMSC pellets and immature or lipopolysaccha-
ride (LPS)‐matured DCs in vitro. Allogeneic chondrogenic hBMSC pellets did not affect
the expression of CD80, CD86, or HLADR on immature or LPS‐matured DCs following
24, 48, or 72 hr of coculture. Furthermore, they did not induce or inhibit antigen uptake
or migration of the DCs over time. IL‐6 was secreted by allogeneic chondrogenic hBMSC
pellets in response to LPS‐matured DCs. Overall, this study has demonstrated that matu-
ration of immature DCs was not influenced by allogeneic chondrogenic hBMSC pellets.
This suggests that allogeneic chondrogenic hBMSC pellets do not stimulate immunogenic
responses fromDCs in vitro and are not expected to indirectly activateT cells via DCs. For
this reason, allogeneic chondrogenic bone marrow stromal cell pellets are promising
candidates for future tissue engineering strategies utilising allogeneic cells for bone repair.
KEYWORDS
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mesenchymal stem cell1 | INTRODUCTION
Bone marrow stromal cells (BMSCs) are multipotent stromal cells with
the capacity to differentiate along adipogenic, osteogenic, and chon-
drogenic lineages (Pittenger et al., 1999). Our group and others have
shown that implantation of chondrogenically differentiated BMSC pellets
into immunodeficient and immunocompetent animals leads to bone
formation in vivo via the process of endochondral ossification (Farrell- - - - - - - - - - - - - - - - - - - - - - - - - - -
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O'Brien, 2014). Undifferentiated BMSCs have been shown to have
unique immunomodulatory characteristics (Bernardo & Fibbe, 2013).
BMSCs have low expression levels of MHC Class I and lack expression
of MHC Class II and T cell costimulatory molecules CD80 (B7.1) and
CD86 (B7.2) on their surface and thus have been shown to not stimulate
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et al., 2006; Ryan et al., 2014; Sudres et al., 2006). It is unclear
whether these immunomodulatory properties are maintained upon differ-
entiation. Allogenic chondrogenically differentiated BMSCs could be used
in a therapy as an alternative to the current gold standard for bone
repair, autologous bone transplantation. For this to become a feasible
option, the interaction between the implanted cells and the host immune
system in the process of the bone formation needs to be fully elucidated.
Although there have been many studies investigating the effects
of undifferentiated BMSCs on host immune cells, little is known about
the effect of chondrogenically differentiated BMSC pellets. Undiffer-
entiated BMSCs are known to have an immunosuppressive effect on
T lymphocytes (Di Nicola et al., 2002; Krampera et al., 2003;
Mougiakakos et al., 2011). In a recent study by our group, direct cocul-
ture of chondrogenically differentiated BMSC pellets and peripheral
blood mononuclear cells (PBMCs) revealed that chondrogenically dif-
ferentiated BMSC pellets did not induce the proliferation of naïve or
stimulated T lymphocytes, suggesting that allogeneic chondrogenically
differentiated BMSC pellets are non‐immunogenic (Kiernan et al.,
2016). However, it is possible that there might be an indirect stimula-
tion of T cells by dendritic cells (DCs) that have encountered these
BMSCs. DCs are the main antigen‐presenting cells (APCs) of the
innate immune system, with a primary role in activating T‐cell‐depen-
dent immune responses (Guermonprez, Valladeau, Zitvogel, Thery, &
Amigorena, 2002). Therefore, the aim of the current research was to
determine if chondrogenically differentiated BMSC pellets affect DCs.
Immature DCs survey the peripheral tissues for potential threats
to the immune system, have low levels of major histocompatibility
complex (MHC) molecules (or human leukocyte antigen [HLA]) and
the costimulatory molecules CD80 and CD86, and are not yet
equipped to stimulate naïve T cells. Antigen uptake and processing
by immature DCs, in addition to locally produced inflammatory cyto-
kines, induce their maturation and migration to the draining lymph
nodes. DC maturation is a prerequisite for the stimulation of naïve
and memory T cells (Lutz & Schuler, 2002). Therefore, DCs present
themselves as potential targets for BMSC‐mediated immunosuppres-
sion. Undifferentiated BMSCs have been shown to inhibit the differ-
entiation, maturation, and function of DCs (Jiang et al., 2005;
Spaggiari, Abdelrazik, Becchetti, & Moretta, 2009; Zhang et al.,
2004), however, little is known about the effect of chondrogenically
differentiated BMSCs on DCs. Chondrogenically differentiated
BMSCs have been reported to be more immunogenic compared with
undifferentiated BMSCs (Chen et al., 2007; Ryan et al., 2014). How-
ever, few studies have directly cocultured chondrogenically differenti-
ated BMSC pellets and immune cells. Undifferentiated BMSCs lack
immunogenicity due to the absence of MHC Class I or costimulatory
molecule expression on their surface, and their ability to secrete
immunosuppressive molecules (PGE2, NO and IDO; Chen, Tredget,
Wu, & Wu, 2008; Meisel et al., 2004; Ryan, Barry, Murphy, & Mahon,
2007; Sato et al., 2007). Chondrogenically differentiated BMSCs in
contrast may lose this immunosuppressive capacity by upregulating
costimulatory molecules on the surface, leading to induced DC matu-
ration and enhanced lymphocyte proliferation (Chen et al., 2007). In
addition to this, the anti‐inflammatory mediators PGE2 and NO have
been shown to be significantly reduced upon chondrogenicdifferentiation of BMSCs, inducing immunogenicity in these cells
(Ryan et al., 2014). Contradictory to these reports, Zheng, Li, Ding,
Jia, and Zhu (2008) demonstrated that chondrogenically differentiated
BMSCs maintain their immunosuppressive behaviour, to conclude that
both undifferentiated and chondrogenically differentiated BMSCs
suppressed T cell responses. Neither of these studies directly
cocultured chondrogenic BMSC pellets with DCs. Therefore, it is clear
that more research is required to confirm the immunomodulatory
capacity of these cells to make them clinically applicable for bone tis-
sue engineering. The aim of the current study was to analyse the
effect of allogeneic chondrogenically differentiated human BMSC pel-
lets on immature and lipopolysaccharide (LPS)‐matured DCs by
directly coculturing them with allogeneic chondrogenically differenti-
ated hBMSC pellets in vitro.2 | MATERIALS AND METHODS
2.1 | Isolation, expansion, and chondrogenic
differentiation of human bone marrow mesenchymal
cells
Human bone marrow stromal cells (hBMSCs) were isolated as previ-
ously described (Kiernan et al., 2016) from heparinised femoral‐shaft
marrow aspirates of patients undergoing total hip arthroplasty (with
informed consent after approval by Erasmus MC medical ethical com-
mittee protocol METC‐2004‐142). hBMSCs were expanded in stan-
dard medium consisting of minimum essential medium alpha medium
(Invitrogen, Carlsbad, CA, USA) supplemented with 10% heat‐
inactivated fetal calf serum (Life Technologies; The Netherlands; lot
number, 41Q2047K); 50‐μg/ml gentamycin; 1.5‐μg/ml fungizone (All
Invitrogen); 1‐ng/ml fibroblast growth factor‐2 (Instruchemie B.V.,
Delfzijl, The Netherlands); and 0.1 mM of L‐ascorbic acid 2‐phosphate
(Sigma‐Aldrich, MO, USA). hBMSCs were cultured at 37 °C under
humidified condition and 5% carbon dioxide, refreshing medium every
3–4 days. Third to fourth passage cells were trypsinised using 0.05%
trypsin (Life Technologies) when they reached 80–90% confluency
and used for BMSC pellet cultures. hBMSCs (0.2 × 106) were added
to 15‐ml polypropylene tubes (Sarstedt) in 0.5 ml of standard
chondrogenic medium consisting of high‐glucose Dulbecco's modified
Eagle's medium with 50‐mg/ml gentamicin; 1.5‐mg/ml Fungizone
(Invitrogen); 100‐mM sodium pyruvate (Sigma‐Aldrich); 1:100 ITS (BD
Biosciences); L‐ascorbic acid 2‐phosphate; 10‐ng/ml TGF‐β3 (Peprotech);
and 100‐nM dexamethasone (Sigma‐Aldrich). Cells were cultured for
10 days with TGFβ3, refreshing the medium every 3–4 days.
2.2 | Generation and culture of monocyte‐derived DCs
PBMCs were isolated from buffy coats of healthy male blood donors
(Sanquin Bloedvoorziening, Rotterdam, The Netherlands), using previ-
ously described methods (Kiernan et al., 2016). Briefly, peripheral
blood was diluted 1:1 in wash medium (RPMI‐1640 medium contain-
ing 1.5‐μg/ml fungizone and 50‐μg/ml gentamycin) and divided into
50‐ml‐filtered falcon tubes containing Ficoll‐Paque PLUS (density
1.077 g/ml; GE Healthcare, Uppsala, Sweden) and centrifuged (690g
no brake, 20 min). The plasma was carefully removed and discarded.
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falcon tube and centrifuged at 835g for 7 min with brake. Following
four washing steps (in wash medium, 690× g for 7 min), monocytes
were separated from freshly obtained PBMCs using the MACS Mono-
cyte Isolation kit (Miltenyi, Biotech) according to manufacturer's
instructions. Briefly, 500 × 106 PBMCs were incubated with 100‐μl
CD14+ MicroBeads for 20 min in the dark at 4 °C, washed and resus-
pended in running buffer (phosphate buffered saline (PBS) with 0.5%
BSA, Sigma, and 2‐mM EDTA, Gibco). Subsequently, magnetically
labelled cells were applied on a column (LS column, Miltenyi, Biotech),
pre‐washed with 5 ml of running buffer) and placed in a MidiMACS
Separator (Miltenyi, Biotech). The CD14+ fraction was collected after
removal of the column from the MidiMACS Separator while collecting
the flow‐through. Afterwards, CD14+ monocytes were washed with
RPMI‐1640 medium (supplemented with 50‐μg/mL Gentamycin and
1.5‐μg/mL Fungizone, both Invitrogen) and cultured in flat‐bottomed
six‐well tissue culture plates at a concentration of 4 × 106 cells in 3‐
ml RPMI‐1640 medium supplemented with 10% FCS (heat‐
inactivated, Gibco), 2‐mM L‐glutamine, 50‐μg/ml Gentamycin,
1.5‐μg/ml Fungizone (all Invitrogen), 50‐ng/ml GM‐CSF (Peprotech),
and 10‐ng/mL IL‐4 (Peprotech) to induce DC differentiation. Every
2 days, half of the medium was refreshed, and monocyte‐derived
DCs were cultured for 6 days (immature DCs). For induction of DC
maturation, LPS (Sigma) was added at 100 ng/ml on Day 5 for 24 hr
(LPS‐matured DCs).2.3 | Chondrogenically differentiated hBMSC
coculture with immature and LPS‐matured DCs
Chondrogenic hBMSC pellets (0.2 × 106 cells at the time of pellet for-
mation) differentiated for 10 days were added to DCs cultured alone
for 6 days (immature DCs), or alone for 5 days, and then stimulated
with LPS for 24 hr (LPS‐matured DCs; 1 × 106 cells) for 24, 48, and
72 hr in 24‐well plates containing supplemented RPMI‐1640.2.4 | Phenotypic analysis of DC populations using
flow cytometry
Following above‐described coculture regimes, DCs were harvested by
pipette aspiration. The chondrogenic hBMSC pellets were removed
prior to the DC harvest. DCs were centrifuged for 8 min at 248g.
The cells were resuspended in FACSflow (BD Biosciences), and
2 × 105 cells per sample were transferred to FACS tubes. Cells centri-
fuged for 5 min at 689g were resuspended in 100 μl of FACSflow con-
taining anti‐CD11c (clone B‐ly6; allophycocyanin), anti‐HLA‐DR (clone
G46‐6; peridinin chlorophyll protein), anti‐CD86 (clone 2331; phyco-
erythrin), anti‐CD80 (clone L307.4; phycoerythrin‐Cy7), anti‐CD14
(fluorescein isothiocyanate [FITC]) antibodies (all BD Biosciences),
and live and dead cell marker (Life Technologies; APC‐Cy7) and incu-
bated for 30 min at 4 °C in the dark. Samples were washed twice with
FACSflow (centrifuged for 5 min at 689g) and resuspended in 200 μl
of FACSflow. Samples were analysed on a FACSJazz (BD Biosciences)
and FlowJo software version 10.0.7 (Treestar Inc.).2.5 | Analysis of DC phagocytic uptake
To study the effect of chondrogenically differentiated hBMSC pellets
on DC phagocytic uptake capacity, 5 × 105 DCs were harvested and
resuspended in 1 ml of PBS containing FITC‐Dextran (1 mg/ml;
Sigma). Cells were transferred back to the 24‐well plates and incu-
bated for 1 hr at 37 °C, or at 4 °C as a control. The DCs were then har-
vested; centrifuged (248g, 8 mins); and resuspended in ice‐cold PBS.
Samples were washed twice with ice‐cold PBS and resuspended in
500 μl of FACSflow. Quantitative uptake of FITC‐Dextran was
analysed by flow cytometry as above.2.6 | Analysis of DC migratory capacity
Cell migration was performed using 24‐well Transwell chambers
(Corning Costar, Cambridge, MA) using 5‐μm pore size polycarbonate
membranes. Immature and LPS‐matured DCs (1 × 105 in 100 μl of
supplemented RPMI‐1640 medium) cultured with chondrogenic
hBMSC pellets were seeded into the upper chamber. Supplemented
RPMI‐1640 medium (600 μl per well) with and without CCL21
(250 ng/ml) was added to the lower chamber. Cells were incubated
for 3 hr at 37 °C. The number of migrated cells was quantified using
Accucheck counting beads according to the manufacturer's instruc-
tions (Invitrogen). Briefly, cells were resuspended in 100 μl of
FACSflow and an equal volume of Accucheck beads. The amount of
counting beads was determined. Because the amount of counting
beads in each samples is equal, the number of migrated cells was cal-
culated. The number of DCs that migrated to normal medium was
subtracted from those that migrated to the medium containing CCL21.2.7 | IL‐6, IL‐10, and IL‐12 secretion from
supernatants from coculture
Supernatants from the cocultures were centrifuged at 690g for 10 min
and stored at −80 °C for later analysis. IL‐6 (Peprotech), IL‐10 (R&D
Systems), and IL‐12 (Peprotech) secretion was determined in the
supernatants from the cocultures using enzyme‐linked immunosor-
bent assay measurements. The measurements were performed and
calculated according to manufacturer's instructions.2.8 | Histological analysis of chondrogenic hBMSC
pellets cultured with DCs
Chondrogenic hBMSC pellets cultured with and without DCs were
harvested, washed in PBS, and then fixed in 4% formalin for 1 hr at
room temperature. Following fixation, pellets were embedded in 3%
agarose, processed, and embedded in paraffin. Sectioned slides were
deparaffinised through alcohol series (xyleen, 100% ethanol, 96% eth-
anol, and 70% ethanol) and rinsed twice in distilled water. For thionine
staining, sections were stained for 5 min with 0.04% thoinin in 0.01‐M
aqueous sodium acetate (pH 4.5) followed by differential staining in
70% ethanol (+/−10 s), 96% ethanol (+/− 30 s), and 100% ethanol
(1 min). For CD11c staining, antigen retrieval was first performed by
heating samples to 80–90°C for 20 min in Dako heat antigen retrieval
solution (S1699, Dako, Heverlee, Belgium). Nonspecific antibody bind-
ing was blocked using 1% milk block in 1% BSA in PBS solution.
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(EP1347Y, Genetex) or rabbit IgG as a negative control antibody
(X0903, Dako Cytomation) and labelled using an alkaline phosphatase
link and label (Biogenex) to identify the presence of DCs within the
matrix of the cells.2.9 | Quantitative real‐time reverse transcription
polymerase chain reaction
Immature and LPS‐matured DCs were removed from the coculture,
washed with PBS, and resuspended in TRIzol reagent (Thermo Scien-
tific). Similarly, chondrogenically differentiated hMSCs were removed
from the coculture, washed with PBS, and crushed in TRIzol reagent.
RNA was isolated from all samples using RNeasy mini kit (Qiagen).
Complementary DNA was synthesised from isolated RNA using first‐
strand complementary DNA synthesis kit (Thermo Scientific) and used
for real‐time reverse transcription polymerase chain reaction (PCR).
Quantitative gene expression was determined using qPCR Mastermix
Plus for SYBR Green I—dTTP (Eurogentec) for the genes IL‐6 (FW:
TCGAGCCCACCGGGAACGAA and RV:GCAGGGAGGGCAGCAG
GCAA) and CCR7 (FW:CAGCCTCCTGTGTGGTTTTAC and RV:CCAG
CACGCTTTTCATTGGTT). Data are represented relative to the house-
keeping gene GAPDH (the 2‐ΔCT method).2.10 | Statistics
Statistical analysis was performed using IBM SPSS Version 21 using a
linear mixed model with Bonferroni post‐test, or GraphPad Prism v.5
for a paired t test or an unpaired t test as indicated in figures. Values
are presented as mean ± standard deviation where p < .05 was consid-
ered statistically significant.3 | RESULTS
3.1 | Chondrogenically differentiated hBMSC pellets
do not induce DC maturation following 24 hr of
coculture
Chondrogenically differentiated hBMSCs cultured in 3D for 10 days
were added to immature or LPS‐matured DCs for 24 hr (Figure 1a)
at a ratio of one BMSC to five DCs. Thionine staining performed on
hBMSC pellets confirmed that they were chondrogenic (Figure S1).
Chondrogenically differentiated hBMSC pellets did not affect the
expression of CD80, CD86, or HLADR in immature DCs (Figure 1b,
c). DCs were successfully matured with the addition of LPS as shown
by the enhanced expression of CD80, CD86, and HLADR in LPS‐
matured DCs (Figure 1b). No additional induction of maturation was
observed in cocultured LPS‐matured DCs after 24 hr. Prolonging the
culturing period again did not affect the maturation of immature
DCs cultured with chondrogenic hBMSC pellets (Figure S2). There
was little difference in the expression of CD80, CD86, and HLADR
in immature DCs cultured with chondrogenic hBMSCs over time. By
72‐hr, maturation marker expression in LPS‐matured DCs reduced.
Furthermore, the percentage of CD11c positive cells began to dimin-
ish after 72 hr in LPS‐matured DCs (Figure S3). These resultsdemonstrate that chondrogenically differentiated hBMSC pellets do
not induce DC maturation.3.2 | Chondrogenically differentiated hBMSC pellets
do not inhibit the antigen uptake capacity in immature
DCs
Antigen uptake capacity as a functional characteristic of immature
DCs was assessed. Upon maturation, DCs lose the capacity to take
up antigen. To assess the ability of chondrogenically differentiated
hBMSC pellets to effect DC antigen uptake capacity, immature and
LPS‐matured DCs cocultured with chondrogenically differentiated
hBMSC pellets were incubated for 1 hr at 37 °C with FITC‐conjugated
dextran. The uptake of dextran by the DCs was analysed by flow
cytometry. No significant increase in dextran uptake was found in
immature DCs cultured with chondrogenic hBMSC pellets compared
with the DCs alone (Figure 2). This demonstrates that immature DCs
have a preserved status regarding taking up antigen and do not mature
as a result of the chondrogenic hBMSC pellets. No difference was
found in the LPS‐matured DCs cultured with chondrogenic hBMSC
pellets. The level in the LPS‐matured DCs (without pellets) was found
to be significantly lower than immature DCs, showing successful
induction of maturation in these cells (84% decrease in mean fluores-
cence intensity). Coculturing the cells for longer time again did not
affect antigen uptake capacity of both immature and LPS‐matured
DCs (Figure S3), indicating that chondrogenically differentiated
hBMSC pellets do not affect DC antigen uptake.3.3 | Immature CD11c positive DCs surround the
periphery of chondrogenic hBMSC pellets
To address the characteristic that DCs stay in proximity to
chondrogenically differentiated hBMSC pellets, hBMSC pellets
cocultured with immature and LPS‐matured DCs were stained for
CD11c. CD11c positive cells were found surrounding the periphery
of chondrogenic hBMSC pellets cultured with both immature and
LPS‐matured DCs (Figure 3a); however, a greater number of positive
cells were found on the pellets cultured with immature DCs
(Figure 3b). Chondrogenic hBMSC pellets alone were negative for
CD11c. This result suggests that immature DCs are interacting with
the chondrogenic hBMSC pellets more than LPS‐matured DCs.3.4 | Chondrogenic hBMSC pellets do not induce DC
migration over time.
Activated DCs develop migratory capacity. This functionality was
tested in a transwell coculture system using immature and LPS‐
matured DCs that were cocultured with chondrogenically differenti-
ated hBMSC pellets for 24, 48, and 72 hr. In this system, the respon-
siveness of both immature and LPS‐matured DCs to CCL21 (a
chemokine that attracts mature DCs) was assessed. Immature and
LPS‐matured DCs (cultured alone) or those cocultured with
chondrogenically differentiated hBMSC pellets were seeded in the
upper chamber of the transwell and CCL21, or control medium was
placed in the bottom chamber. After 3 hr, the absolute cell number
FIGURE 1 Chondrogenically differentiated human bone marrow stromal cell (hBMSC) pellets do not induce dendritic cell (DC) maturation
following 24 hr in coculture. Immature or lipopolysaccharide (LPS)‐matured DCs were cultured alone (black) or with chondrogenically
differentiated hBMSC pellets (grey) for 24 hr. (a [i]) Thionine staining confirmed the chondrogenicity of hBMSC pellets following 28 days in
chondrogenic medium. (a [ii]) Following 24 hr in RPMI‐medium, hBMSC pellets were still chondrogenic. (a [iii] and [iv]) Following 24 hr of coculture
with immature and LPS‐mature DCs, hBMSC pellets were still chondrogenic. (b) Microscopic images following 24 hr of culture demonstrate the
morphology of the cocultured cells. (c and d) Flow cytometric analysis revealed no difference in the expression of the maturation markers CD80,
CD86, and HLADR in immature DCs cocultured with chondrogenically differentiated hBMSC pellets. (c) Horizontal bars represent positive regions
gated from unstained controls. (d) Data represented as the mean fluorescence intensity (MFI). n = 9 (three different hBMSC and DC donors in
triplicate). Linear mixed model with Bonferroni post‐test *p < .05, **p < .005, and ***p < .001 [Colour figure can be viewed at wileyonlinelibrary.com]
1534 KIERNAN ET AL.was determined by flow cytometry. After 24 hr in coculture, a slightly
higher number of immature DCs migrated in coculture with
chondrogenically differentiated hBMSC pellets; however, this was
not significant (9,145 ± 1,783 vs. 12,204 ± 1,706 cells; Figure 4a).
By 48 and 72 hr, there was still no significant difference in the migra-
tion of immature DCs and those cocultured with chondrogenic
hBMSCs. In the LPS‐matured DCs, there was a trend towards lessmigration in coculture with chondrogenic hBMSC pellets at 24 hr
(29,046 ± 2,934 vs. 25,104 ± 197 cells) and 48 hr in coculture
(48,065 ± 1,600 vs. 42,269 ± 4,604 cells), but this was not statistically
significant. No difference in migration was found in LPS‐matured DCs
cocultured with chondrogenic hBMSC pellets for 72 hr (31,754 ± 865
vs. 31,792 ± 1,600 cells). Uptake and presentation of antigen of DCs
during the immune response also lead to the upregulation of CCR7
FIGURE 2 Chondrogenic human bone marrow stromal cell (hBMSC) pellets do not inhibit antigen uptake capacity in immature dendritic cells
(DCs). Immature and lipopolysaccharide (LPS)‐matured DCs were harvested following 24 hr coculture with chondrogenically differentiated
hBMSC pellets and incubated with fluorescein isothiocyanate (FITC)‐conjugated dextran for 1 hr at 37or 4 °C as a negative control. Chondrogenic
hBMSC pellets did not affect antigen uptake in immature DCs. LPS‐matured DCs alone and those cultured with chondrogenic hBMSC pellets
demonstrated reduced FITC‐dextran uptake as a result of DC maturation. Chondrogenic hBMSC pellets did not affect FITC‐dextran uptake in LPS‐
matured DCs. Data represented as the mean fluorescence intensity (MFI) ± SD. Horizontal bars represent positive regions gated from 4 °C
negative controls. n = 9 (three different hBMSC and DC donors in triplicate). Linear mixed model with Bonferroni post‐test *p < .05, **p < .005, and
***p < .001
FIGURE 3 CD11c positive cells were found surrounding the periphery of chondrogenic human bone marrow stromal cell (hBMSC) pellets
cultured with immature dendritic cells (DCs). (a) CD11c immunohistochemistry was performed on chondrogenic hBMSC pellets cultured with
immature and lipopolysaccharide (LPS)‐matured DCs. (b) The total number of CD11c positive cells (indicated by black arrows) were counted. n = 9
(three different hBMSC and DC donors in triplicate) ± SD. Paired t test *p < .05, **p < .005, and ***p < .001 [Colour figure can be viewed at
wileyonlinelibrary.com]
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FIGURE 4 Chondrogenically differentiated human bone marrow stromal cell (hBMSC) does not induce dendritic cell (DC) migration over time.
Immature (black) and lipopolysaccharide (LPS)‐matured (grey) DCs were harvested following 24, 48, and 72 hr of coculture with
chondrogenically differentiated hBMSC pellets. The DCs from the coculture were seeded in the upper chamber of the transwell system, and
CCL21 or control medium was placed in the lower chamber. DCs were incubated for 3 hr at 37 °C. The cells that had migrated were harvested,
and an equal amount of counting beads was added to the samples. Samples were analysed by flow cytometry, and the absolute cell count for each
sample was calculated. (a) The number of cells spontaneously migrating to control medium was subtracted from the cells that migrated to CCL21.
(b) The level of CCR7 gene expression was measured in immature and LPS‐matured DCs cultured with chondrogenically differentiated hBMSC
pellets. n = 3 (one hBMSC and one DC donor in triplicate at three timepoints) ± SD. Linear mixed model with Bonferroni post‐test *p < .05,
**p < .005, and ***p < .001
1536 KIERNAN ET AL.(Forster, Davalos‐Misslitz, & Rot, 2008). No difference was found in
the CCR7 expression between immature DCs and those cultured with
chondrogenic hBMSC pellets (Figure 4b). CCR7 gene expression was
upregulated in LPS‐matured DCs cocultured with chondrogenic
hBMSC pellets following 24 hr in coculture, and this was maintained
for 72 hr. As expected, chondrogenic hBMSC pellets did not express
CCR7 from any culture conditions (data not shown). These results
show that chondrogenic hBMSC pellets do not induce DC migration.3.5 | IL‐6 is secreted at high levels in the
supernatants from cocultures of chondrogenic hBMSC
pellets with LPS‐matured DCs
DCs produce cytokines upon maturation and activation. Interleukin 6
(IL‐6) is a pleiotropic molecule exhibiting both an anti‐ and pro‐inflam-
matory effects depending on the situation. Supernatants from the
coculture of immature and LPS‐matured DCs cultured with
chondrogenically differentiated hBMSC pellets for 24, 48, or 72 hr
were harvested. An IL‐6 enzyme‐linked immunosorbent assay was
performed on all supernatants. There was no significant difference in
the secretion of IL‐6 between immature and LPS‐matured DCs over
time. Low levels of IL‐6 were produced from chondrogenically differ-
entiated hBMSC pellets cultured alone. However, in the cocultured
conditions, a significantly higher level of IL‐6 production was found
in supernatants from cocultures of LPS‐matured DCs and
chondrogenically differentiated hBMSC pellets following 24 hr of
coculture (Figure 5a). This level of IL‐6 secretion was consistently
higher in cocultures of LPS‐matured DCs and chondrogenic hBMSC
pellets over time. To investigate which one of the cell types might
be responsible for the IL‐6 production, qPCR for IL‐6 was performedon harvested chondrogenic hBMSC pellets and DCs separately. At
gene expression level, IL‐6 was found to be upregulated in
chondrogenic hBMSC pellets from the coculture of both immature
and LPS‐matured DCs after 24 hr (Figure 5b,c). IL‐6 was consistently
expressed by chondrogenic hBMSC pellets more than LPS‐matured
DCs when cocultured over time. In coculture with immature DCs,
chondrogenic hBMSCs expressed higher levels of IL‐6 after 24 hr in
coculture, and this level became reduced over time. These results sug-
gest the chondrogenic hBMSCs secrete IL‐6 in response to LPS‐
matured DCs.4 | DISCUSSION
The immunomodulatory properties of undifferentiated hBMSCs have
been widely studied (Aggarwal & Pittenger, 2005; Di Ianni et al.,
2008; Di Nicola et al., 2002; Jiang et al., 2005; Nauta, Kruisselbrink,
Lurvink, Willemze, & Fibbe, 2006; Roemeling‐van Rhijn et al., 2013;
Zhang et al., 2004); however, it is uncertain whether differentiated
hBMSCs maintain these immunomodulatory properties.
Chondrogenically differentiated hBMSC pellets have been shown to
form bone in both immunodeficient and immunocompetent animals
(Farrell et al., 2011). The use of allogeneic chondrogenically differenti-
ated hBMSCs could provide a novel “off the shelf” treatment for the
repair of bone defects; however, the role of the host cells in the pro-
cess of the bone formation by allogeneic chondrogenic hBMSCs still
needs to be established. Our group has previously shown that
chondrogenically differentiated hBMSC pellets do not directly induce
T cell responses following 7‐day in vitro culture (Kiernan et al.,
2016). Due to the fact that DCs are the key players in stimulating T
FIGURE 5 IL‐6 is secreted in supernatants from cocultures of immature and lipopolysaccharide (LPS)‐matured dendritic cells (DCs). (a)
Supernatants from immature and LPS‐matured DCs were harvested following 24, 48, and 72 hr in culture with chondrogenically differentiated
human bone marrow stromal cell (hBMSCs). n = 3 (one different hBMSC and DC donor in triplicate) ± SD. Linear mixed model with Bonferroni
post‐test *p < .05, **p < .005, and ***p < .001. (c) The level of IL6 gene expression was measured in immature and LPS‐matured DCs cultured alone
or with chondrogenically differentiated hBMSC pellets (black) and also in chondrogenic hBMSC pellets cultured alone or with immature and LPS‐
matured DCs (grey) over time. Chondrogenic hBMSC pellets expressed higher levels of IL‐6 compared with immature and LPS‐matured DCs. n = 3
(one different hBMSC and DC donors in triplicate at three timepoints) ± SD. Unpaired t test *p < .05, **p < .005, and ***p < .001
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chondrogenically differentiated hBMSC pellets on the maturation
and function of immature and LPS‐matured DCs in vitro. We have
shown that allogeneic chondrogenic hBMSC pellets do not induce
DC maturation in vitro.
DCs are known to express the important costimulatory molecules
CD80 and CD86 upon maturation, which are ligands for CD28 to
induce T cell activation (Sharpe & Freeman, 2002). HLADR (an MHC
Class II cell surface receptor) is also expressed to present antigen to
T cells via their T cell receptor. Low levels of MHC expression on
DCs are known to result in T cell anergy (Chung, Ysebaert, Berneman,
& Cools, 2013). To assess the effect of allogeneic chondrogenic
hBMSC pellets on DCs, allogeneic chondrogenically differentiated
hBMSC pellets were cocultured with immature and LPS‐matured
DCs for 24 hr. The levels of CD80, CD86, and HLADR expression in
immature DCs cultured with allogeneic chondrogenic hBMSC pellets
for 24 hr were not affected. To determine if allogeneic chondrogenic
hBMSC pellets would induce maturation over time, the experiment
was repeated for 48 and 72 hr. After 48 hr, coculture with
chondrogenic hBMSC pellets again did not affect the expression of
CD80, CD86, and HLADR in immature DCs or LPS‐matured DCs.
Noticeably after 72 hr, the expression of CD11c was diminished in
LPS‐matured DCs alone and cultured with allogeneic hBMSC pellets.
Furthermore, there were decreases in expression of CD80, CD86,
and HLADR in all samples compared with 48 hr. LPS‐matured DCs
began to closely resemble the morphology of immature DCs after
72 hr in culture. Long culturing periods of LPS‐matured DCs have
been shown to exhaust the cells; however, these cells may still be
responsive to other cues and still may have the ability to go on toactivate T cells (Abdi, Singh, & Matzinger, 2012; Iwamoto, Ishida,
Takahashi, Takeda, & Miyazaki, 2005). LPS has also been shown to
induce a population of DCs lowly expressing CD11c that are unable
to stimulate T cells but have the capacity to induce regulatory T cells
(Wang et al., 2015). We hypothesize that the LPS‐matured DCs cul-
tured alone and with allogeneic chondrogenic hBMSC pellets were
maximally stimulated at 48 hr and began to decrease after this time,
as seen by the drop in CD11c expression by 72 hr. Further research
would be required to determine whether these DCs have the ability
to activate T cell responses.
Few studies have studied the effects of chondrogenically differ-
entiated BMSC pellets on DCs. One study investigated the effect of
chondrogenically differentiated BMSCs in monolayer on DCs and
reported that chondrogenically differentiated BMSCs induce DC mat-
uration shown by increased CD83 expression. Other surface markers
such as HLADR, CD14, and CD1a were not significantly different in
the cocultures (Chen et al., 2007). Technau, Froelich, Hagen, and
Kleinsasser (2011) investigated the immunomodulatory properties of
chondrogenically differentiated adipose‐derived stem cells and found
upregulation of HLADR and enhanced secretion of the pro‐inflamma-
tory cytokine IFNγ. However, they concluded that chondrogenically
differentiated adipose‐derived stem cells have both immunogenic
and immunosuppressive properties shown by upregulation of anti‐
inflammatory cytokines in the chondrogenic cells. Overall, allogeneic
chondrogenically differentiated hBMSC pellets did not affect matura-
tion of DCs.
The effect of allogeneic chondrogenic hBMSCs on the function of
immature and LPS‐matured DCs was also assessed. Antigen uptake
capacity of DCs has been shown to be inhibited by undifferentiated
1538 KIERNAN ET AL.hBMSCs (Jiang et al., 2005). Chondrogenically differentiated hBMSC
pellets again did not induce FITC‐dextran uptake in immature DCs
over time. By 72 hr of coculture, there was slightly less FITC‐dextran
uptake in immature DCs cocultured with allogeneic chondrogenic
hBMSC pellets suggesting that immature DCs were either prevented
from taking up antigen or perhaps these immature DCs had become
mature by 72‐hr coculture with allogeneic chondrogenic hBMSC pel-
lets. However, the level of FITC‐dextran in immature DCs never
reached the levels of LPS‐matured DCs. The level of DC maturity
needed for successful activation of T cells would be important to
investigate in future studies. Upon maturation, DCs lose the capacity
for antigen uptake and are induced to migrate to T cell rich areas of
the lymph node. Immature DCs cultured with allogeneic chondrogenic
hBMSCs were not induced to migrate compared with the control.
Allogeneic chondrogenic hBMSC pellets had no significant effect on
LPS‐matured DC antigen uptake or migratory capacity.
Interestingly, it appears from this study that IL‐6 appears to play
an important role in the interaction between allogeneic chondrogenic
hBMSCs and DCs. IL‐6 is a pleiotropic cytokine known to be essential
in the development of APCs (Chomarat, Banchereau, Davoust, &
Palucka, 2000; Xing et al., 1998). It has been previously shown that
IL‐6 could be responsible for the ability of undifferentiated BMSCs
to inhibit DC functions (Djouad et al., 2007; Jiang et al., 2005). Follow-
ing 24 hr of coculture, it was found that IL‐6 was significantly secreted
in supernatants from cultures of LPS‐matured DCs and allogenic
chondrogenic hBMSC pellets and this continued over 48 and 72 hr
of coculture. At mRNA level, IL‐6 expression was found to be signifi-
cantly increased by allogeneic chondrogenic hBMSC pellets cultured
with LPS‐matured DCs demonstrating that the allogeneic
chondrogenic hBMSCs were responsible for the production of the
IL‐6. It has been hypothesised that IL‐6 secretion by undifferentiated
BMSCs maintains the CD14 monocyte population as opposed to spe-
cifically inhibiting the DCs (Jiang et al., 2005). However, all of the DCs
were CD14 negative in coculture with chondrogenic hBMSC pellets.
Although there was no clear effect of allogeneic chondrogenic hBMSC
pellets on maturation or function of LPS‐matured DCs at 24 or 48 hr,
IL‐6 production appears to be produced by the pellets in response to
LPS‐matured DCs. It is possible that this was why there was no altered
behaviour of the DCs. The secretion of IL‐10 and IL‐12 was also mea-
sured in the supernatants. IL‐10 was not secreted by either immature
DCs or immature DCs cocultured with allogeneic hBMSC pellets after
24 hr (Figure S4). It was secreted by chondrogenically differentiated
BMSC pellets cultured alone, LPS‐matured DCs and LPS‐matured
DCs cocultured with chondrogenic hBMSC pellets. However, there
was no significant difference in the secretion of IL‐10 between cocul-
tures. IL‐12 is known to be involved in the differentiation and function
of naïve T cells into effector cells (Hsieh et al., 1993). IL‐12 was found
to be secreted in both immature and LPS‐matured DCs cocultured
with allogeneic chondrogenically differentiated hBMSCs for 24 hr.
However, there was no significant difference in IL‐12 secretion
between conditions. Over time, the level of IL‐12 secretion was also
measured in supernatants (Figure S5). It was found that IL‐12 was
secreted at higher levels in supernatants from cocultured LPS‐matured
DCs and chondrogenic hBMSC pellets following 48 and 72 hr,
although at a much lower concentration in comparison to IL‐6. Thesecretion of both IL‐6 and IL‐12 might lead ultimately to the induction
of specific T cell responses, or the balance between these cytokines
might prevent T cell activation by DCs.
In conclusion, we show for the first time that allogeneic
chondrogenic hBMSC pellets do not induce maturation of immature
DCs in comparison with LPS‐matured DCs. We did not observe strong
immune responses from these DCs in coculture over time. Further-
more, they had no immunomodulatory effects on LPS‐matured DCs;
however, IL‐6 appears to be an important cytokine secreted by alloge-
neic chondrogenic hBMSC pellets in response to LPS‐matured DCs.
Hall marks of DC activation are elevated levels of costimulatory mole-
cules, reduced capacity for antigen uptake, migration and the produc-
tion of cytokines. Here, we show that none of these characteristics
were induced in immature DCs cocultured with allogeneic
chondrogenic hBMSC pellets. Therefore, complete maturation of
immature DCs was not influenced by allogeneic chondrogenic hBMSC
pellets. Overall, this study demonstrated that allogeneic chondrogenic
hBMSC pellets do not induce DC maturation in vitro and are promis-
ing candidates for future bone tissue‐engineering strategies.
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Supplementary Figure 1 – Chondrogenically differentiated hBMSC pellets
effect DC maturation over time. Immature (black) and LPS‐matured DCs
(grey) were harvested following 24, 48 and 72 hours of co‐culture
with chondrogenically differentiated hBMSC pellets. Flow cytometric
analysis illustrated the increased expression of the maturation markers
CD80, CD86 and HLADR in immature DCs following 24 hours of co‐
culture with chondrogenically differentiated hBMSC pellets (a). The
expression of the maturation markers followed a similar trend towards
an increase at 48 hours but no difference was observed after 72 hours.
The expression of CD80 and 86 increased in LPS‐matured DCs cul-
tured with chondrogenic hBMSCs for 48 and 72 hours (c). Data repre-
sented as the mean fluorescence intensity (MFI). Samples were
analysed on separate days based on unstained control. n = 3(1 different hBMSC and DC donors in triplicate at 3 timepoints) ± SD
Unpaired t‐test *p < 0.05, **p < 0.005, ***p < 0.001
Supplementary Figure 2 – LPS‐matured DCs lose CD11c expression after
72 hours in culture. Supplementary figure 3 illustrates the representa-
tive plots from the flow cytometry results of the extended culture of
immature (a) and LPS‐matured DCs (b). The level of CD11c expression
became depleted on LPS‐matured DCs alone and also those co‐cul-
tured with chondrogenic hBMSC pellets following 72 hours in culture.
Supplementary Figure 3 – Chondrogenically differentiated hBMSC pellets
do not continue to induce antigen uptake over time. Immature (black)
and LPS‐matured (grey) DCs were harvested following 24, 48 and
72 hours of co‐culture with chondrogenically differentiated hBMSC
pellets and incubated with FITC‐conjugated dextran for 1 hour at
37°C or 4°C as a negative control. Immature DCs cultured with
chondrogenic hBMSC pellets did not continue to take up antigen over
time compared to immature DCs only (a). There was a reduction in the
level of FITC‐dextran uptake in immature DCs cultured with
chondrogenically differentiated hBMSC pellets after 72 hours. LPS‐
matured DCs alone and those cultured with chondrogenic hBMSC pel-
lets demonstrated reduced FITC‐dextran uptake as a result of DC mat-
uration (b). Chondrogenic hBMSC pellets did not affect FITC‐dextran
uptake in LPS‐matured DCs after 48 hours of co‐culture however they
slightly induced antigen uptake after 72 hours. Data represented as
the mean fluorescence intensity (MFI). n = 3 (1 hBMSC donor and
1 DC donor in triplicate ±SD). Linear mixed model with Bonferroni
post‐test *p < 0.05, **p < 0.005, ***p < 0.001
Supplementary Figure 4 – Secretion of IL‐10 and IL‐12 was not signifi-
cantly affected in supernatants of co‐cultures of LPS‐matured DCs and
chondrogenic hBMSC pellets. Supernatants from immature and LPS‐
matured DCs were harvested following 24 hours in culture with
chondrogenically differentiated hBMSC pellets. There was no signifi-
cant difference in the secretion of IL‐10 or IL‐12 between conditions.
n = 9 (3 hBMSC and 3 different DC donors in triplicate) ± SD. Linear
mixed model with Bonferroni post‐test *p < 0.05, **p < 0.005,
***p < 0.001
Supplementary Figure 5 – IL‐12 continued to be secreted over time in
supernatants of co‐cultures of LPS‐matured DCs and chondrogenic
hBMSC pellets. Supernatants from immature and LPS‐matured DCs
were harvested following 24, 48 and 72 hours in culture with
chondrogenically differentiated hBMSCs. IL‐12 was secreted at higher
levels in supernatants harvested from co‐culture of immature DCs and
chondrogenic hBMSC pellets for 24 hours. The level of IL‐12 was
highest in supernatants of LPS‐matured DCs cultured with
chondrogenic hBMSC pellets following 48 and 72 hours. IL‐12 was
not secreted by chondrogenic hBMSC pellets only. n = 3 (1 hBMSC
and 1 DC donor in triplicate) ± SD. Linear mixed model with
Bonferroni post‐test *p < 0.05, **p < 0.005, ***p < 0.001
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